Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-γc-/- mice

Journal of Virology

Volumn 81, Issue 6, 2007, Pages 2700-2712

  Gorantla, Santhi ^a   Sneller, Hannah ^a   Walters, Lisa ^a   Sharp, John G ^b   Pirruccello, Samuel J ^a   West, John T ^c   Wood, Charles ^c   Dewhurst, Stephen ^d   Gendelman, Howard E ^a   Poluektova, Larisa ^a,e  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CCR5; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RAG2 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL MATURATION; CONTROLLED STUDY; FETUS LIVER; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN PRODUCTION; LYMPH NODE; LYMPHADENOPATHY; MAMMAL; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THYMUS; UMBILICAL CORD BLOOD; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TYPING; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD34; B-LYMPHOCYTES; BUSULFAN; COBALT RADIOISOTOPES; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAMMA RAYS; GRAFT SURVIVAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIV-1; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOABLATIVE AGONISTS; RECEPTORS, CCR5; T-LYMPHOCYTES; THYMUS GLAND; TRANSPLANTATION, HETEROLOGOUS; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; MUS;

EID: 33947356676     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02010-06     Document Type: Article

References (33)

1. Aldrovandi, G. M., G. Feuer, L. Gao, B. Jamieson, M. Kristeva, I. S. Chen, and J. A. Zack. 1993. The SC1D-hu mouse as a model for HIV-1 infection. Nature 363:732-736.
2. Andersen, R. W., K. I. Matthews, D. A. Crouse, and J. G. Sharp. 1982. In vitro evaluation of hematopoiesis in mice treated with busulphan or nitrogen mustard. Biomed. Pharmacother. 36:149-152.
3. Binley, J. M., P. J. Klasse, Y. Cao, I. Jones, M. Markowitz, D. D. Ho, and J. P. Moore. 1997. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J. Virol. 71:2799-2809.
4. Botnick, L. E., E. C. Hannon, and S. Hellman. 1979. Nature of the hemopoietic stem cell compartment and its proliferative potential. Blood Cells 5:195-210.
5. Cole, K. S., M. Murphey-Corb, O. Narayan, S. V. Joag, G. M. Shaw, and R. C. Montelaro. 1998. Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. J. Virol. 72:7852-7859.
6. Gendelman, H. E., J. M. Orenstein, M. A. Martin, C. Ferrua, R. Mitra, T. Phipps, L. A. Wahl, H. C. Lane, A. S. Fauci, and D. S. Burke. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp. Med. 167:1428-1441.
7. -/- mice: functional inactivation of p53 in developing T cells. Blood 104:3886- 3893.
8. Gobbi, A., C. A. Stoddart, M. S. Malnati, G. Locatelli, F. Santoro, N. W. Abbey, C. Bare, V. Linquist-Stepps, M. B. Moreno, B. G. Herndier, P. Lusso, and J. M. McCune. 1999. Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. J Exp. Med. 189:1953-1960.
9. Gupta, V., H. M. Lazarus, and A. Keating. 2003. Myeloablative conditioning regimens for AML allografts: 30 years later. Bone Marrow Transplant. 32:969-978.
10. Hellman, S., L. E. Botnick, E. C. Hannon, and R. M. Vigneulle. 1978. Proliferative capacity of murine hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 75:490-494.
11. + cells using the NOD/SCID/gammacnull mice model. Blood 102:873-880.
12. Ishihara, S., N. Tachibana, A. Okayama, K. Murai, K. Tsuda, and N. Mueller. 1992. Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody. Jpn. J. Cancer Res. 83:320-323.
13. Ishikawa, F., M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chain(null) mice. Blood 106:1565-1573.
14. Ito, M., H. Hiramatsu, K. Kobayashi, K. Suzue, M. Kawahata, K. Hioki, Y. Ueyama, Y. Koyanagi, K. Sugamura, K. Tsuji, T. Heike, and T. Nakahata. 2002. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175-3182.
15. -/- mice. Blood 108:238-245.
16. Legrand, N., K. Weijer, and H. Spits. 2006. Experimental models to study development and function of the human immune system in vivo. J. Immunol. 176:2053-2058.
17. Macchiarini, F., M. G. Manz, A. K. Palucka, and L. D. Shultz. 2005. Humanized mice: are we there yet? J Exp. Med. 202:1307-1311.
18. Mazurier, F., A. Fontanelles, S. Salesse, L. Taine, S. Landriau, F. Moreau-Gaudry, J. Reiffers, B. Peault, J. P. Di Santo, and H. de Verneuil. 1999. A novel immunodeficient mouse model-RAG2 x common cytokine receptor gamma chain double mutants-requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J. Interferon Cytokine Res. 19:533-541.
19. McCune, J., H. Kaneshima, J. Krowka, R. Namikawa, H. Outzen, B. Peault, L. Rabin, C. C. Shih, E. Yee, M. Lieberman, et al. 1991. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu. Rev. Immunol. 9:399-429.
20. + T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:5236-5242.
21. Mosier, D. E., R. J. Gulizia, S. M. Baird, D. B. Wilson, D. H. Spector, and S. A. Spector. 1991. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251:791-794.
22. Namikawa, R., H. Kaneshima, M. Lieberman, I. L. Weissman, and J. M. McCune. 1988. Infection of the SCID-hu mouse by HIV-1. Science 242: 1684-1686.
23. Poluektova, L. Y., D. H. Munn, Y. Persidsky, and H. E. Gendelman. 2002. Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J. Immunol. 168:3941-3949.
24. Rozemuller, H., S. Knaan-Shanzer, A. Hagenbeek, L. van Bloois, G. Storm, and A. C. Martens. 2004. Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes. Exp. Hematol. 32:1118-1125.
25. Schauer, U., F. Stemberg, C. H. Rieger, W. Buttner, M. Borte, S. Schubert, H. Mollers, F. Riedel, U. Herz, H. Renz, and W. Herzog. 2003. Levels of antibodies specific to tetanus toxoid, Haemophilia influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin. Diagn. Lab Immunol. 10:202-207.
26. Shultz, L. D., B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, D. L. Greiner, and R. Handgretinger. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174:5477-6489.
27. Traggiai, E., L. Chicha, L. Mazzucchelli, L. Bronx, J. C. Piflaretti, A. Lanzavecchia, and M. G. Manz. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104-107.
28. Trkola, A., H. Kuster, C. Leemann, A. Oxenius, C. Fagard, H. Furrer, M. Battegay, P. Vernazza, E. Bernasconi, R. Weber, B. Hirschel, S. Bonhoefler, and H. F. Gunthard. 2004. Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point. Blood 104:1784-1792.
29. van Maanen, M., and R. E. Sutton. 2003. Rodent models for HIV-1 infection and disease. Curr. HIV Res. 1:121-130.
30. Watanabe, S., K. Terashima, S. Ohta, S. Horibata, M. Yajima, Y. Shiozawa, M. Z. Dewan, Z. Yu, M. Ito, T. Morio, N. Shimizu, M. Honda, and N. Yamamoto. 15 September 2006. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rγ null mice develop human lymphoid system and induce long-lasting HIV-I infection with specific humoral immune responses. Blood doi:10.11.1182/blood-2005-04-017681. (Subsequently published, Blood 109: 212-218, 2007.)
31. + cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J. Immunol. 169:204-209.
32. Yoder, M. C., J. G. Cumming, K. Hiatt, P. Mukherjee, and D. A. Williams. 1996. A novel method of myeloablation to enhance engraftment of adult bone marrow cells in newborn mice. Biol. Blood Marrow Transplant. 2:59-67.
33. Zhang, H., F. Hoffmann, J. He, X. He, C. Kankasa, R. Ruprecht, J. T. West, G. Orti, and C. Wood. 2005. Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant. Retrovirology 2:67.